These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22238367)

  • 1. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
    Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
    Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma.
    Huang J; Zhang X; Zhang M; Zhu JD; Zhang YL; Lin Y; Wang KS; Qi XF; Zhang Q; Liu GZ; Yu J; Cui Y; Yang PY; Wang ZQ; Han ZG
    Carcinogenesis; 2007 May; 28(5):1094-103. PubMed ID: 17114643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
    Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
    Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
    Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
    PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma.
    Yu F; Hao X; Zhao H; Ge C; Yao M; Yang S; Li J
    Liver Int; 2010 May; 30(5):703-14. PubMed ID: 20214740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma.
    Zou S; Wang C; Liu J; Wang Q; Zhang D; Zhu S; Xu S; Kang M; He S
    Mol Cells; 2017 Nov; 40(11):847-854. PubMed ID: 29127951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M; Mu XD; Song JR; Zhai PT; Cheng Y; Le Y; Li ZB
    Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
    Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
    Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
    J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
    Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progenitor gene DLK1 might be an independent prognostic factor of liver cancer.
    Jin ZH; Yang RJ; Dong B; Xing BC
    Expert Opin Biol Ther; 2008 Apr; 8(4):371-7. PubMed ID: 18352842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.
    Wong NC; Cheung PF; Yip CW; Chan KF; Ng IO; Fan ST; Cheung ST
    Mol Cancer Ther; 2014 Dec; 13(12):3001-12. PubMed ID: 25253787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.